Men with high-risk prostate cancer have a higher likelihood of residual disease after prostatectomy and may require radiation ...

The phase 2/3 NRG GU002 trial (NCT03070886) evaluated whether adding 6 cycles of docetaxel after radiation and androgen ...

Five-treatment stereotactic body radiation therapy (SBRT) provided excellent long-term cancer control with fewer urinary and ...

Men with prostate cancer face different long-term risks depending on whether they choose surgery or radiation therapy, with ...

Patients with prostate cancer can receive radiation after prostatectomy in 25 treatments over 5 weeks instead of 37 treatments over 7 weeks. Long-term data from the NRG-GU003 tria ...

Radiation therapy starts damaging cancer cells during treatment, but most cells do not die immediately. Radiation works ...

Five-treatment stereotactic body radiation therapy (SBRT) provided excellent long-term cancer control with fewer urinary and ...

A prespecified analysis of a phase 3 trial evaluated the ability of PAM50 molecular prostate cancer subtypes to predict benefit from salvage treatment intensification.

UCLA investigators present the latest radiotherapy research at the American Society for Radiation Oncology annual meeting ...

Men with high-risk prostate cancer have a higher likelihood of having residual disease following prostatectomy and may require radiation therapy after surgery, particularly when PSA levels begin to ...

September 30, 2026, 10:01 to October 7, 2026, 10:01 (JST)This week, progress was made in preparing for U.S. regulatory ...

Stereotactic body radiation therapy significantly improved quality of life outcomes, including urinary incontinence and ...